IKZF2 and T-cell acute lymphoblastic leukemia: A recent study highlighted the upregulation of IKZF2 in human cutaneous TCL and proposed its potential as a target gene for treatment (Figure 2B) (30), as well as in T-cell acute lymphoblastic leukemia in humans (31).